Repligen (RGEN) Capital Expenditures Growth (5y) (2015 - 2026)
Repligen (RGEN) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.84 Bn | 121.63 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.96 Bn | 44.15 Bn | 2.15 Bn |
| 3 | Alcon | 33.16 Bn | 31.50 Bn | 1.53 Bn |
| 4 | Medline | 32.82 Bn | 30.58 Bn | 1.84 Bn |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.41 Bn | 22.97 Bn | 329.20 Mn |
| 7 | Solventum | 14.09 Bn | 13.53 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.85 Bn | 13.71 Bn | 735.40 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Repligen | 7.45 Bn | 6.47 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.00% |
| Dec 31, 2025 | -46.83% |
| Sep 30, 2025 | -54.11% |
| Jun 30, 2025 | 18.71% |
| Mar 31, 2025 | -26.80% |
| Dec 31, 2024 | -24.96% |
| Sep 30, 2024 | 20.32% |
| Jun 30, 2024 | -15.29% |
| Mar 31, 2024 | -16.58% |
| Dec 31, 2023 | -33.78% |
| Sep 30, 2023 | 23.19% |
| Jun 30, 2023 | 23.67% |
| Mar 31, 2023 | 40.32% |
| Dec 31, 2022 | -11.79% |
| Sep 30, 2022 | -7.26% |
| Jun 30, 2022 | -9.29% |
| Mar 31, 2022 | -4.53% |
| Dec 31, 2021 | -106.63% |
| Sep 30, 2021 | 73.99% |
| Jun 30, 2021 | -49.75% |